Literature DB >> 26793379

Developments in oncological positron emission tomography/computed tomography assessment.

Carsten Kobe1, Ronald Boellaard1, Jürgen Wolf1, Georg Kuhnert1, Markus Dietlein1, Bernd Neumaier1, Alexander Drzezga1, Deniz Kahraman1.   

Abstract

Year:  2015        PMID： 26793379      PMCID： PMC4703688          DOI： 10.3978/j.issn.2072-1439.2015.12.45

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  16 in total

1.  Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET.

Authors:  Jianhua Yan; Jason Lim Chu-Shern; Hoi Yin Loi; Lih Kin Khor; Arvind K Sinha; Swee Tian Quek; Ivan W K Tham; David Townsend
Journal:  J Nucl Med       Date:  2015-07-30       Impact factor: 10.057

2.  Tumor Texture Analysis in PET: Where Do We Stand?

Authors:  Irène Buvat; Fanny Orlhac; Michaël Soussan
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

3.  Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.

Authors:  Deniz Kahraman; Matthias Scheffler; Thomas Zander; Lucia Nogova; Adriaan A Lammertsma; Ronald Boellaard; Bernd Neumaier; Roland T Ullrich; Arne Holstein; Markus Dietlein; Jürgen Wolf; Carsten Kobe
Journal:  J Nucl Med       Date:  2011-11-07       Impact factor: 10.057

4.  Spatial Tumor Heterogeneity in Lung Cancer with Acquired Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance: Targeting High-Level MET-Amplification and EGFR T790M Mutation Occurring at Different Sites in the Same Patient.

Authors:  Matthias Scheffler; Sabine Merkelbach-Bruse; Marc Bos; Jana Fassunke; Masyar Gardizi; Sebastian Michels; Laura Groneck; Anne M Schultheis; Florian Malchers; Frauke Leenders; Carsten Kobe; Katharina König; Lukas C Heukamp; Martin L Sos; Roman K Thomas; Reinhard Büttner; Jürgen Wolf
Journal:  J Thorac Oncol       Date:  2015-06       Impact factor: 15.609

5.  Non-Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of (18)F-FDG Uptake at PET-Association with Treatment Response and Prognosis.

Authors:  Gary J R Cook; Mary E O'Brien; Muhammad Siddique; Sugama Chicklore; Hoi Y Loi; Bhupinder Sharma; Ravi Punwani; Paul Bassett; Vicky Goh; Sue Chua
Journal:  Radiology       Date:  2015-04-17       Impact factor: 11.105

6.  Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma.

Authors:  C Kobe; G Kuhnert; H Haverkamp; M Fuchs; D Kahraman; H-T Eich; J Kriz; C Baues; B Nast-Kolb; P J Bröckelmann; P Borchmann; A Drzezga; A Engert; M Dietlein
Journal:  Nuklearmedizin       Date:  2015-09-21       Impact factor: 1.379

7.  Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis.

Authors:  Georg Kuhnert; Ronald Boellaard; Sergej Sterzer; Deniz Kahraman; Matthias Scheffler; Jürgen Wolf; Markus Dietlein; Alexander Drzezga; Carsten Kobe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-18       Impact factor: 9.236

Review 8.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

9.  Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.

Authors:  Markus Dietlein; Carsten Kobe; Georg Kuhnert; Simone Stockter; Thomas Fischer; Klaus Schomäcker; Matthias Schmidt; Felix Dietlein; Boris D Zlatopolskiy; Philipp Krapf; Raphael Richarz; Stephan Neubauer; Alexander Drzezga; Bernd Neumaier
Journal:  Mol Imaging Biol       Date:  2015-08       Impact factor: 3.488

Review 10.  False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review.

Authors:  Anastasia Chalkidou; Michael J O'Doherty; Paul K Marsden
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.